LOINC
Version 2.73

100709-5Hepatocellular carcinoma risk [Score] by GAADActive

Term Description

The GAAD score is used to predict the probability of developing early-stage hepatocellular carcinoma (HCC). It is calculated based on gender, age, alpha-fetoprotein (AFP), and des-gamma-carboxy prothrombin (DCP, also called PIVKA-II). In contrast, the GALAD score [LOINC:96450-2] includes AFP-L3. The risk-factor score ranges from 0-10 where a higher GAAD scores correlate with increased risk of HCC.
Source: Regenstrief LOINC

Fully-Specified Name

Component
Hepatocellular carcinoma risk
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
GAAD

Additional Names

Short Name
Hep Ca Risk Score Patient GAAD
Display Name
Hepatocellular carcinoma risk GAAD [Score]
Consumer Name Alpha
Hepatocellular carcinoma risk

Basic Attributes

Class
CHEM
Type
Laboratory
First Released
Version 2.73
Last Updated
Version 2.73
Order vs. Observation
Both

Member of these Groups

LG51398-2 Hepatocellular carcinoma risk|Score|Pt|^Patient

Example Units

Unit Source
{score} Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=100709-5